University of California San Diego Altman Clinical and Translation Research Institute — La Jolla, California

University of California San Diego Altman Clinical and Translation Research Institute is a clinical research site located in La Jolla, California, United States 92037.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of California San Diego Altman Clinical and Translation Research Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Embolization, Vascular Tumor, Renal Angiomyolipoma.

Sponsors: Fluidx Medical Technology, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California San Diego Altman Clinical and Translation Research Institute?

University of California San Diego Altman Clinical and Translation Research Institute has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California San Diego Altman Clinical and Translation Research Institute conducted?

University of California San Diego Altman Clinical and Translation Research Institute has 1 clinical trials on record, with 1 currently active. Their work covers Embolization, Vascular Tumor, Renal Angiomyolipoma.

Is University of California San Diego Altman Clinical and Translation Research Institute accredited by Crixeo Health?

University of California San Diego Altman Clinical and Translation Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California San Diego Altman Clinical and Translation Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.